These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 29092627

  • 1. Evidence Based Review of Pharmacotherapy for Opioid-Induced Constipation in Noncancer Pain.
    Murphy JA, Sheridan EA.
    Ann Pharmacother; 2018 Apr; 52(4):370-379. PubMed ID: 29092627
    [Abstract] [Full Text] [Related]

  • 2. Opioid-induced constipation in chronic noncancer pain.
    Weber HC.
    Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):11-7. PubMed ID: 26702846
    [Abstract] [Full Text] [Related]

  • 3. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
    Holder RM, Rhee D.
    Pharmacotherapy; 2016 Mar; 36(3):287-99. PubMed ID: 26945548
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis.
    Nee J, Zakari M, Sugarman MA, Whelan J, Hirsch W, Sultan S, Ballou S, Iturrino J, Lembo A.
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1569-1584.e2. PubMed ID: 29374616
    [Abstract] [Full Text] [Related]

  • 5. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
    Candy B, Jones L, Vickerstaff V, Larkin PJ, Stone P.
    Cochrane Database Syst Rev; 2018 Jun 05; 6(6):CD006332. PubMed ID: 29869799
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation.
    White WB, Kowey P, Diva U, Sostek M, Tummala R.
    J Cardiovasc Pharmacol Ther; 2018 Jul 05; 23(4):309-317. PubMed ID: 29504415
    [Abstract] [Full Text] [Related]

  • 7. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation.
    Jones R, Prommer E, Backstedt D.
    Am J Hosp Palliat Care; 2016 Nov 05; 33(9):875-880. PubMed ID: 26150678
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation.
    Webster L, Chey WD, Tack J, Lappalainen J, Diva U, Sostek M.
    Aliment Pharmacol Ther; 2014 Oct 05; 40(7):771-9. PubMed ID: 25112584
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Off-label uses of alvimopan and methylnaltrexone.
    Rodriguez RW.
    Am J Health Syst Pharm; 2014 Sep 01; 71(17):1450-5. PubMed ID: 25147168
    [Abstract] [Full Text] [Related]

  • 15. Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.
    Lawson R, Ryan J, King F, Goh JW, Tichy E, Marsh K.
    Pharmacoeconomics; 2017 Feb 01; 35(2):225-235. PubMed ID: 27663572
    [Abstract] [Full Text] [Related]

  • 16. Naloxegol rescue with methylnaltrexone highly effective.
    Brocklebank J, Miller EJ, Fingas S.
    BMJ Support Palliat Care; 2020 Sep 01; 10(3):316-317. PubMed ID: 32709705
    [Abstract] [Full Text] [Related]

  • 17. Treatment with Naloxegol Versus Placebo: Pain Assessment in Patients with Noncancer Pain and Opioid-Induced Constipation.
    Webster L, Diva U, Tummala R, Sostek M.
    Pain Pract; 2018 Apr 01; 18(4):505-514. PubMed ID: 28898536
    [Abstract] [Full Text] [Related]

  • 18. Naloxegol: the first orally administered, peripherally acting, mu opioid receptor antagonist, approved for the treatment of opioid-induced constipation.
    Corsetti M, Tack J.
    Drugs Today (Barc); 2015 Aug 01; 51(8):479-89. PubMed ID: 26380386
    [Abstract] [Full Text] [Related]

  • 19. Drugs for Treating Opioid-Induced Constipation: A Mixed Treatment Comparison Network Meta-analysis of Randomized Controlled Clinical Trials.
    Sridharan K, Sivaramakrishnan G.
    J Pain Symptom Manage; 2018 Feb 01; 55(2):468-479.e1. PubMed ID: 28919541
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.